Demystifying buprenorphine misuse: Has fear of diversion gotten in the way of addressing the opioid crisis?
Demystifying buprenorphine misuse: Has fear of diversion gotten in the way of addressing the opioid crisis?
复制标题
DOI：
10.1080/08897077.2019.1572052
复制
发表时间：
2019-04-19
期刊：
影响因子：
3.5
通讯作者：
Fingerhood, Michael
中科院分区：
文献类型：
--
作者：
Doernberg, Molly;Krawczyk, Noa;Fingerhood, Michael
丁丙诺啡被认为是阿片类药物使用障碍最有效的治疗方法之一，可显著降低过量死亡的风险。然而，在公共讨论以及在设计有关其使用的做法和政策时，对它的转移和滥用的关切往往占据中心位置。这损害了许多脆弱的病人群体，特别是那些涉及刑事司法系统的人。由于担心转移而限制在刑事司法和其他环境中获得丁丙诺啡的政策没有准确反映与之相关的相对风险和安全性，造成了不必要的障碍，推动了这种急需药物的非法市场。虽然对所有受控药物的适当监管应该是优先事项，但在大多数情况下，丁丙诺啡的益处远远超过其风险。在国家危机中，努力的重点应该是扩大而不是限制获得这种拯救生命的治疗。
Buprenorphine is considered one of the most effective treatments for opioid use disorder and significantly reduces risk of overdose death. However, concerns about its diversion and misuse have often taken center stage in public discourse and in the design of practices and policies regarding its use. This has been to the detriment of many vulnerable patient populations, especially those involved in the criminal justice system. Policies that restrict access to buprenorphine in criminal justice and other settings due to concerns of diversion do not accurately reflect the relative risks and safety profile associated with it, creating unnecessary barriers that drive an illicit market of this much-needed medication. Although proper regulation of all controlled medications should be a priority, in most instances the benefits of buprenorphine highly outweigh its risks. In the midst of a national crisis, efforts should be focused on expanding, and not restricting, access to this lifesaving treatment.